EUVIMEDEUVIMED entdecken
Open Access

Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated Inflammatory Reaction following Intraportal Transplantation

Ali Turan iD, Mohammad Tarique iD, Lei Zhang iD, Shadab Kazmi iD, Vahap Ulker iD, Mebrahtu G Tedla iD, Darshan Badal iD, Esma S Yolcu iD, Haval Shirwan iD

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2300743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Ali Turan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Department of Molecular Microbiology and Immunology, NextGen Precision Health Institute, Ellis Fischel Cancer Center, Un…. Hauptthemen laut MEDLINE: CD47 Antigen, Inflammation, Islets of Langerhans, Islets of Langerhans Transplantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most pancreatic islets are destroyed immediately after intraportal transplantation by an instant blood-mediated inflammatory reaction (IBMIR) generated through activation of coagulation, complement, and proinflammatory pathways. Thus, effective mitigation of IBMIR may be contingent on the combined use of agents targeting these pathways for modulation. CD47 and thrombomodulin (TM) are two molecules with distinct functions in regulating coagulation and proinflammatory responses. We previously reported that the islet surface can be modified with biotin for transient display of novel forms of these two molecules chimeric with streptavidin (SA), that is, thrombomodulin chimeric with SA (SA-TM) and CD47 chimeric with SA (SA-CD47), as single agents with improved engraftment following intraportal transplantation. This study aimed to test whether islets can be coengineered with SA-TM and SA-CD47 molecules as a combinatorial approach to improve engraftment by inhibiting IBMIR. Mouse islets were effectively coengineered with both molecules without a detectable negative impact on their viability and metabolic function. Coengineered islets were refractory to destruction by IBMIR ex vivo and showed enhanced engraftment and sustained function in a marginal mass syngeneic intraportal transplantation model. Improved engraftment correlated with a reduction in intragraft innate immune infiltrates, particularly neutrophils and M1 macrophages. Moreover, transcripts for various intragraft procoagulatory and proinflammatory agents, including tissue factor, HMGB1 (high-mobility group box-1), IL-1β, IL-6, TNF-α, IFN-γ, and MIP-1α, were significantly reduced in coengineered islets. These data demonstrate that the transient codisplay of SA-TM and SA-CD47 proteins on the islet surface is a facile and effective platform to modulate procoagulatory and inflammatory responses with implications for both autologous and allogeneic islet transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD47 AntigenInflammationIslets of LangerhansIslets of Langerhans TransplantationMice, Inbred C57BLThrombomodulinAnimalsMaleMiceStreptavidin

Substanzen

CD47 AntigenStreptavidinThrombomodulinTHBD protein, mouseCd47 protein, mouse

Autor:innen und Institutionen

  • Department of Pediatrics and Department of Molecular Microbiology and Immunology, NextGen Precision Health Institute, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO.

ORCID-Profile: Ali Turan, Mohammad Tarique, Lei Zhang, Shadab Kazmi, Vahap Ulker, Mebrahtu G Tedla, Darshan Badal, Esma S Yolcu, Haval Shirwan

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)

Zitieren

APA

Turan, A., Tarique, M., Zhang, L., Kazmi, S., Ulker, V., Tedla, M. G., Badal, D., Yolcu, E. S., & Shirwan, H. (2024). Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated Inflammatory Reaction following Intraportal Transplantation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300743

Vancouver

Turan A, Tarique M, Zhang L, Kazmi S, Ulker V, Tedla MG, et al. Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated Inflammatory Reaction following Intraportal Transplantation. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300743

BibTeX
@article{Turan2024,
  author = {Turan, Ali and Tarique, Mohammad and Zhang, Lei and Kazmi, Shadab and Ulker, Vahap and Tedla, Mebrahtu G and Badal, Darshan and Yolcu, Esma S and Shirwan, Haval},
  title = {Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated Inflammatory Reaction following Intraportal Transplantation},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2300743}
}
Kostenlos starten →